(S1 (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NN E2F8)) (, ,) (NP (NP (DT a) (JJ novel) (JJ E2F-like) (JJ cell-cycle) (JJ regulated) (NN repressor)) (PP (IN of) (NP (JJ E2F-activated) (NN transcription)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN E2F) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors)))) (VP (VP (VBP are) (NP (NP (JJ downstream) (NNS effectors)) (PP (IN of) (NP (NP (DT the) (NN retinoblastoma) (NN protein)) (, ,) (NP (NN pRB)) (, ,) (NP (NN pathway)))))) (CC and) (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (JJ timely) (NN regulation)) (PP (IN of) (NP (NP (NNS genes)) (ADJP (JJ necessary) (PP (IN for) (NP (JJ cell-cycle) (NN progression)))))))))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT the) (NN characterization)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN E2F8)) (, ,) (NP (NP (DT a) (JJ new) (NN member)) (PP (IN of) (NP (DT the) (NN E2F) (NN family))))))))) (. .)))
(S1 (S (S (NP (NP (NN Sequence) (NN analysis)) (PP (IN of) (NP (NN E2F8)))) (VP (VBZ predicts) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (CD two) (JJ distinct) (JJ E2F-related) (NN DNA) (NN binding) (NNS domains)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN E2F8)) (CC and) (, ,) (ADVP (DT the) (ADVP (RB recently))) (, ,) (NP (VBN identified) (NN E2F7))) (VP (VBP form) (NP (NP (DT a) (NN subgroup)) (PP (IN within) (NP (DT the) (NN E2F) (NN family))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NN E2F) (NN transcription) (NNS factors)) (VP (VBP bind) (NP (DT the) (NN E2F8) (NN promoter)) (ADVP (FW in) (FW vivo))))) (CC and) (SBAR (IN that) (S (NP (NP (NN expression)) (PP (IN of) (NP (NN E2F8)))) (VP (VBZ is) (VP (VBG being) (VP (VBN induced) (PP (IN at) (NP (DT the) (NN G1/S) (NN transition))))))))))) (. .)))
(S1 (S (S (NP (VBN Purified) (JJ recombinant) (NN E2F8)) (VP (VBZ binds) (ADVP (RB specifically)) (PP (TO to) (NP (NP (DT a) (NN consensus) (NN E2F-DNA-binding) (NN site)) (VP (VBG indicating) (SBAR (IN that) (S (NP (NN E2F8)) (, ,) (PP (IN like) (NP (NN E2F7))) (, ,) (VP (VBZ binds) (NP (NN DNA)) (PP (IN without) (NP (NP (DT the) (NN requirement)) (PP (IN of) (NP (NP (NNS co-factors)) (PP (JJ such) (IN as) (NP (NN DP1))))))))))))))) (. .)))
(S1 (S (S (NP (NN E2F8)) (VP (VBZ inhibits) (NP (NP (JJ E2F-driven) (NNS promoters)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN E2F8)) (VP (VBZ is) (NP (NP (JJ transcriptional) (NN repressor)) (PP (IN like) (NP (NN E2F7))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Ectopic) (NN expression)) (PP (IN of) (NP (NN E2F8))) (PP (IN in) (NP (JJ diploid) (JJ human) (NNS fibroblasts)))) (VP (VP (VBZ reduces) (NP (NP (NN expression)) (PP (IN of) (NP (JJ E2F-target) (NNS genes))))) (CC and) (VP (VBZ inhibits) (NP (NP (NN cell) (NN growth)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN for) (S (VP (VBG repressing) (NP (NN E2F) (JJ transcriptional) (NN activity)))))))))))) (. .)))
(S1 (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN E2F8)) (VP (VBZ has) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (VBG turning)) (PP (IN of) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ E2F-target) (NNS genes))) (PP (IN in) (NP (NP (DT the) (NN S-phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))))))))))) (. .)))
